Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, and Other Drug Classes), and By Region, Competition 2018-2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

 

Forecast Period

2024-2028

Market Size (2022)

USD 18.45 billion

CAGR (2024-2028)

8.33%

Fastest Growing Segment

Asia Pacific

Largest Market

North America

 

Market Overview

Global Dermatological Therapeutics Market has valued at USD 18.45 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.33% through 2028. Dermatological therapeutics refers to the branch of medicine that focuses on the diagnosis, treatment, and management of disorders and conditions affecting the skin, hair, nails, and mucous membranes. Dermatology is a medical specialty that deals with a wide range of skin-related issues, from common conditions like acne and eczema to complex disorders such as skin cancer and autoimmune diseases. Dermatological therapeutics encompasses various approaches to care, including medical, surgical, and cosmetic treatments, with the goal of maintaining or improving skin health and appearance. Dermatological therapeutics often involve the use of pharmaceuticals, including topical creams, ointments, oral medications, and biologic therapies, to treat various skin disorders. These treatments aim to alleviate symptoms, reduce inflammation, control infections, and modify the underlying disease process.

The increasing incidence of skin disorders such as acne, psoriasis, eczema, skin cancer, and fungal infections is a significant driver for the dermatological therapeutics market. As the population ages and environmental factors continue to affect skin health, the demand for treatment options rises. Growing awareness of skincare and aesthetic concerns, driven by social media, beauty trends, and the desire for youthful appearance, has led to increased demand for dermatological products and procedures, including anti-aging treatments and cosmeceuticals. Innovations in biotechnology, including the development of biologic therapies and personalized medicine approaches, have led to more targeted and effective treatments for various skin conditions, such as psoriasis and atopic dermatitis. As disposable incomes rise in emerging markets and among the middle class globally, individuals have greater access to dermatological treatments and skincare products.

Key Market Drivers

Rising Awareness and Aesthetic Concerns

 Aesthetic concerns related to aging, such as fine lines, wrinkles, and age spots, drive the demand for anti-aging dermatological products and procedures. This includes the use of topical creams, injectables like Botox, and laser treatments. Many individuals seek dermal fillers to enhance facial volume and achieve a more youthful appearance. These treatments often fall under the domain of dermatological therapeutics. Chemical peels are used for skin rejuvenation, improving skin texture, and addressing aesthetic concerns like pigmentation irregularities. Aesthetic concerns about scars, whether from surgery, acne, or injuries, lead to the demand for scar management products and treatments. The desire for brighter and more even-toned skin has driven the market for dermatological products that address issues such as hyperpigmentation and melasma. Acne is a common skin condition that can lead to aesthetic concerns, especially when it results in scarring. Dermatological therapeutics, including prescription and over-the-counter products, are sought after for acne management and scar reduction.

Increasing awareness of the damaging effects of UV radiation and the importance of sun protection has led to greater use of dermatological products like sunscreens and skin cancer prevention therapies. The influence of social media, beauty influencers, and celebrity endorsements has made people more conscious of their appearance and skincare routines. This has contributed to the demand for a wide range of dermatological products. Consumers have access to more information than ever before, allowing them to educate themselves about skincare and the benefits of dermatological products. This education often leads to increased product adoption. Dermatological therapeutics have become more personalized to meet individual skincare needs. Customized skincare regimens, often recommended by dermatologists, have gained popularity. The preference for minimally invasive aesthetic procedures, such as laser therapy and microdermabrasion, has grown due to reduced downtime and natural-looking results. Celebrities openly discussing their skincare routines and endorsements of specific products or treatments can significantly influence consumer choices and boost demand. The globalization of beauty ideals, where clear and healthy skin is considered universally attractive, has led to the global demand for dermatological products and treatments. This factor will help in the development of Global Dermatological Therapeutics Market.

Advancements in Biotechnology

Biotechnology has led to the development of innovative and targeted treatments for various skin conditions. Biotechnology has enabled the creation of biologic drugs for dermatological conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa. These drugs, often monoclonal antibodies, target specific molecules in the immune system or inflammatory pathways, providing more precise and effective treatments with fewer side effects. Biotechnological advancements have facilitated personalized medicine in dermatology. Genetic testing and biomarker analysis allow dermatologists to tailor treatments to an individual's genetic makeup and disease characteristics, enhancing treatment efficacy and safety. Biotechnology has led to the development of advanced drug delivery systems, such as nanoparticles and liposomes, which enhance the penetration of therapeutic agents into the skin. This innovation improves the effectiveness of topical dermatological treatments. Biotechnology has given rise to regenerative medicine approaches in dermatology. Stem cell therapy and tissue engineering hold promise for repairing damaged skin and treating conditions like chronic wounds and scars. Biotechnological tools, including genetic sequencing and molecular diagnostics, enable more precise and early diagnosis of dermatological conditions. Timely and accurate diagnosis drives the demand for appropriate therapeutics. Biotechnology has led to the development of biocompatible and bioresorbable materials used in dermatological treatments, such as dermal fillers and sutures, for aesthetic and reconstructive purposes.

Biotechnology has improved the ability to culture skin cells and tissues in the laboratory. This facilitates research, drug testing, and the development of novel dermatological therapies. Ongoing research in gene therapy holds promise for treating genetic skin disorders by correcting or replacing faulty genes. Although in its early stages, gene therapy has the potential to revolutionize dermatological therapeutics. Advances in biotechnology have expanded the use of immunotherapy for skin cancer treatment. Immune checkpoint inhibitors and other immunotherapeutic agents have shown efficacy in treating melanoma and other skin cancers. Biotechnology has enabled the development of biology for rare dermatological conditions, addressing previously unmet medical needs and increasing access to effective treatments. Biotech companies invest heavily in dermatological research and development, leading to a pipeline of innovative products and therapies that drive the market forward. This factor will pace up the demand of Global Dermatological Therapeutics Market.

Increase in Disposable Income

With higher disposable income, individuals are more willing and able to invest in premium skincare products. This includes high-end moisturizers, serums, and specialty creams, which are often considered part of dermatological skincare. An increase in disposable income allows individuals to afford cosmeceutical products that bridge the gap between cosmetics and pharmaceuticals. Additionally, people may opt for aesthetic dermatological treatments, such as chemical peels, microdermabrasion, and laser therapy, which can be costly but provide visible results. Higher income levels often mean better access to dermatologists and skincare specialists. People can seek professional advice and receive personalized treatment plans, including prescription dermatological therapeutics, when necessary. Affluent individuals may choose to undergo advanced dermatological procedures like Botox injections, dermal fillers, and laser resurfacing to address aging concerns and skin imperfections.

People with higher disposable income may be more inclined to invest in high-quality sunscreens and sun-protective clothing to prevent sun damage and reduce the risk of skin cancer. Individuals with higher incomes can afford long-term treatment regimens for chronic skin conditions such as psoriasis, eczema, and acne, including prescription medications and biologic therapies. Rising income levels often lead to the adoption of holistic skincare routines that encompass a range of dermatological therapeutics, including cleansers, moisturizers, and specialty treatments. The ability to afford preventive and anti-aging dermatological products allows individuals to proactively address skin concerns, maintain youthful skin, and prevent the progression of skin conditions. People with higher disposable incomes may travel to seek dermatological treatments or aesthetic procedures in countries known for their advanced medical facilities and expertise. Medical spas offering a combination of clinical skincare treatments and relaxation services are popular among individuals with disposable income, driving demand for various dermatological procedures. Some affluent consumers prefer customized and boutique skincare solutions, including personalized skincare formulations tailored to their specific needs. Higher-income individuals may be drawn to luxury skincare brands that offer exclusive and premium dermatological products. This factor will accelerate the demand of Global Dermatological Therapeutics Market.


Download Free Sample Report

Key Market Challenges

Generic Competition

When generic versions of dermatological drugs become available, they are often sold at significantly lower prices than their branded counterparts. This can lead to price erosion for the branded products, reducing their market share and profitability. Branded dermatological products typically have patent protection for a certain period, during which they enjoy exclusivity in the market. When these patents expire, generic manufacturers can enter the market with lower-cost alternatives, reducing the market share of the original brand. The introduction of generic versions of dermatological drugs can result in a sharp decline in sales revenue for the pharmaceutical companies that developed and marketed the branded products. Generic competition can intensify competition within the dermatological therapeutics market, which can, in turn, lead to pricing pressures and reduced profit margins for both branded and generic manufacturers. As more generic versions of a dermatological drug become available, the market can become fragmented, with multiple manufacturers offering similar products. This fragmentation can make it challenging for dermatologists and patients to choose among various generic options. Healthcare providers, including dermatologists, may increasingly prescribe generic dermatological drugs to reduce healthcare costs. This can lead to a decline in the use of branded products.

Market Saturation

When multiple companies offer similar dermatological products for the same conditions, competition can become intense. This competition may lead to price wars, reducing profit margins for all players. With a saturated market, companies may lower prices to gain a competitive edge, which can result in reduced overall revenue and profitability. In a saturated market, it becomes increasingly difficult for companies to capture additional market share, as most potential customers are already using existing products. When numerous products treat the same dermatological conditions, it can be challenging for companies to differentiate their offerings based on efficacy or other factors. Market saturation can discourage investment in research and development for new dermatological therapies, as companies may perceive limited opportunities for significant returns on investment. Rather than developing groundbreaking treatments, companies may focus on making incremental improvements to existing products to maintain market share. Established brands may have an advantage in saturated markets due to existing customer loyalty, making it harder for newer entrants to gain traction.

Key Market Trends

Personalized Medicine

Advances in genetics and genomics have allowed dermatologists to analyze a patient's genetic profile to better understand their susceptibility to certain skin conditions or their response to specific treatments. Genetic testing can help identify genetic markers associated with conditions like psoriasis or melanoma, enabling personalized treatment plans. Dermatologists are increasingly using biomarkers, which are specific molecules or genetic markers found in a patient's skin or blood, to assess the severity of skin conditions and predict their response to certain therapies. This helps tailor treatment approaches for better outcomes. With a deeper understanding of the molecular mechanisms underlying skin disorders, dermatologists can prescribe targeted therapies, including biologics and small molecule inhibitors, that specifically address the pathways contributing to a patient's condition. This approach minimizes side effects and maximizes treatment efficacy. Compounded topical treatments can be personalized to suit an individual's skin type, condition, and sensitivities. Dermatologists may work with compounding pharmacists to create customized formulations tailored to the patient's needs. Personalized medicine allows dermatologists to identify individuals at higher risk of skin cancers or other dermatological conditions. This enables more proactive surveillance and preventive measures, such as regular skin cancer screenings or tailored skincare routines.

Segmental Insights

Drug Class Insights

In 2022, the Global Dermatological Therapeutics Market largest share was held by Anti-infectives segment in the forecast period and is predicted to continue expanding over the coming years. Skin infections, including bacterial, fungal, and viral infections, are common dermatological conditions worldwide. These infections can range from minor to severe and require medical treatment. As a result, there is a consistent demand for anti-infective dermatological therapeutics. Acne is a widespread skin condition often caused or exacerbated by bacterial infection. Acne treatments, including topical and oral antibiotics, fall under the anti-infectives category and have been widely prescribed. Certain viral skin infections, such as herpes simplex and shingles (herpes zoster), require antiviral medications as part of their treatment.

Application Insights

In 2022, the Global Dermatological Therapeutics Market largest share was held by Psoriasis segment and is predicted to continue expanding over the coming years.  Chronic autoimmune skin disease called psoriasis quickens the development cycle of skin cells. On the elbows, face, palms, knees, scalp, lower back, and soles of feet, it results in regions of thickly red skin with silvery scales. Plaque psoriasis, the most prevalent kind, is brought on by mistaken T-cell attacks on the skin. The segment's growth is anticipated to be aided by the rising prevalence of psoriasis, the rising number of clinical trials for psoriasis drug development, and the rising advances by key market participants.


Download Free Sample Report

Regional Insights

The North America region dominates the Global Dermatological Therapeutics Market in 2022. North America boasts a well-developed healthcare infrastructure, including many dermatology clinics and healthcare providers specializing in skin disorders. North America is home to many leading pharmaceutical companies and research institutions that invest heavily in dermatological research and product development. This region often leads in the development of new therapies and treatments. Skin conditions like acne, psoriasis, eczema, and skin cancer are prevalent in North America, contributing to the demand for dermatological therapeutics.

Recent Developments

  • In January 2022, RINVOQ was approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe atopic dermatitis in adults and children 12 years of age and older whose condition has not responded to prior therapy and has not been adequately controlled by other pills or injections, including biologic medications, or in cases where using other pills or injections is not advised. Children 12 years of age and older and adults who weigh at least 40 kg can start taking RINVOQ 15 mg once daily.1The dose may be increased to 30 mg once daily in young kids and adults under 65 who do not receive an acceptable response.
  • In July 2022, The U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older, according to Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing significant innovations in immuno-dermatology. ZORYVE, the first and only topical PDE4 inhibitor licenced for the treatment of plaque psoriasis, offers quick clearing of psoriasis plaques, and lessens itching over the entire body. ZORYVE, a once-daily, steroid-free cream with a patient-friendly composition, is specially designed to make plaque psoriasis care easier for those with the condition.
  • In September 2022, For the treatment of adult patients with moderate-to-severe plaque psoriasis who are eligible for systemic therapy or phototherapy, the FDA has approved deucravacitinib (Sotyktu, Bristol Myers Squibb). Results from the phase 3 POETYK PSO-1 and POETYK PSO-2 clinical studies were used to support the approval of the first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor. Deucravacitinib demonstrated greater efficacy in both studies compared to placebo and twice-daily apremilast (Otezla) in 1684 patients with moderate-to-severe plaque psoriasis who were 18 years of age and older. At 16 and 24 weeks, deucravacitinib's greater efficacy was seen, and responses persisted for 52 weeks compared to placebo and apremilast.

Key Market Players

  • Abbvie Inc. (Allergan PLC)
  • Almirall SA
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company

By Application

By Drug Class

By Region

By Region
  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Atopic Dermatitis
  • Other Applications
  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Other Drug Classes
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • South America
  • Saudi Arabia
  • UAE
  • Qatar
  • Kuwait
  • Bahrain
  • Rest of Middle East

Report Scope:

In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Dermatological Therapeutics Market, By Application:

o    Alopecia

o    Herpes

o    Psoriasis

o    Rosacea

o    Atopic Dermatitis

o    Other Applications

  • Dermatological Therapeutics Market, By Drug Class:

o    Anti-infectives

o    Corticosteroids

o    Anti-acne

o    Calcineurin Inhibitors

o    Retinoids

o    Other Drug Classes

  • Dermatological Therapeutics Market, By region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.

Available Customizations:

Global Dermatological Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Dermatological Therapeutics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.   Markets Covered

1.2.2.   Years Considered for Study

1.2.3.   Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Impact of COVID-19 on Global Dermatological Therapeutics Market

5.    Voice of Customer

6.    Global Dermatological Therapeutics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications)

6.2.2.     By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, and Other Drug Classes)

6.2.3.     By Region

6.2.4.     By Company (2022)

6.3.  Market Map

7.    Asia Pacific Dermatological Therapeutics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By Drug Class

7.2.3.     By Country

7.3.  Asia Pacific: Country Analysis

7.3.1.     China Dermatological Therapeutics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Application

7.3.1.2.2.             By Drug Class

7.3.2.     India Dermatological Therapeutics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Application

7.3.2.2.2.             By Drug Class

7.3.3.     Australia Dermatological Therapeutics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Application

7.3.3.2.2.             By Drug Class

7.3.4.     Japan Dermatological Therapeutics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Application

7.3.4.2.2.             By Drug Class

7.3.5.     South Korea Dermatological Therapeutics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Application

7.3.5.2.2.             By Drug Class

8.    Europe Dermatological Therapeutics Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By Drug Class

8.2.3.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Dermatological Therapeutics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Application

8.3.1.2.2.             By Drug Class

8.3.2.     Germany Dermatological Therapeutics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Application

8.3.2.2.2.             By Drug Class

8.3.3.     Spain Dermatological Therapeutics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Application

8.3.3.2.2.             By Drug Class

8.3.4.     Italy Dermatological Therapeutics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Application

8.3.4.2.2.             By Drug Class

8.3.5.     United Kingdom Dermatological Therapeutics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Application

8.3.5.2.2.             By Drug Class

9.    North America Dermatological Therapeutics Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Application

9.2.2.     By Drug Class

9.2.3.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Dermatological Therapeutics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Application

9.3.1.2.2.             By Drug Class

9.3.2.     Mexico Dermatological Therapeutics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Application

9.3.2.2.2.             By Drug Class

9.3.3.     Canada Dermatological Therapeutics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Application

9.3.3.2.2.             By Drug Class

10.  South America Dermatological Therapeutics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Application

10.2.2.  By Drug Class

10.2.3.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Dermatological Therapeutics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Application

10.3.1.2.2.           By Drug Class

10.3.2.  Argentina Dermatological Therapeutics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Application

10.3.2.2.2.           By Drug Class

10.3.3.  Colombia Dermatological Therapeutics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Application

10.3.3.2.2.           By Drug Class

11.  Middle East and Africa Dermatological Therapeutics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Application

11.2.2.  By Drug Class

11.2.3.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Dermatological Therapeutics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Application

11.3.1.2.2.           By Drug Class

11.3.2.  Saudi Arabia Dermatological Therapeutics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Application

11.3.2.2.2.           By Drug Class

11.3.3.  UAE Dermatological Therapeutics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Application

11.3.3.2.2.           By Drug Class

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

13.1.              Recent Developments

13.2.              Product Launches

13.3.              Mergers & Acquisitions

14.  Global Dermatological Therapeutics Market: SWOT Analysis

15.  Porter’s Five Forces Analysis

15.1.              Competition in the Industry

15.2.              Potential of New Entrants

15.3.              Power of Suppliers

15.4.              Power of Customers

15.5.              Threat of Substitute Product

16.  PESTLE Analysis

17.  Competitive Landscape

17.1.              Business Overview

17.2.              Company Snapshot

17.3.              Products & Services

17.4.              Financials (In case of listed companies)

17.5.              Recent Developments

17.6.              SWOT Analysis

17.6.1.  Abbvie Inc. (Allergan PLC)

17.6.2.  Almirall SA

17.6.3.  Amgen Inc.

17.6.4.  Bausch Health Companies Inc.

17.6.5.  Galderma SA

17.6.6.  GlaxoSmithKline PLC

17.6.7.  Johnson & Johnson

17.6.8.  Novartis AG

17.6.9.  Pfizer Inc.

17.6.10.                Bristol-Myers Squibb Company

18.  Strategic Recommendations

19. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Dermatological Therapeutics Market was estimated to be USD 18.45 billion in 2022.

down-arrow

Johnson & Johnson, Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company are some of the key players operating in the Global Dermatological Therapeutics Market.

down-arrow

Changes in regulations or more stringent requirements can pose challenges for companies in bringing new dermatological products to market.

down-arrow

Biologic drugs, including monoclonal antibodies, were gaining prominence in the treatment of skin conditions such as psoriasis, eczema, and acne.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Global Dermatological Therapeutics Market to grow with a CAGR of 8.33%.

Sep, 2023

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Dermatological Therapeutics Market.

Why Choose Us